JP2013513607A5 - - Google Patents

Download PDF

Info

Publication number
JP2013513607A5
JP2013513607A5 JP2012543187A JP2012543187A JP2013513607A5 JP 2013513607 A5 JP2013513607 A5 JP 2013513607A5 JP 2012543187 A JP2012543187 A JP 2012543187A JP 2012543187 A JP2012543187 A JP 2012543187A JP 2013513607 A5 JP2013513607 A5 JP 2013513607A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutically acceptable
salt
group
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012543187A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013513607A (ja
JP5631411B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/059158 external-priority patent/WO2011071840A1/en
Publication of JP2013513607A publication Critical patent/JP2013513607A/ja
Publication of JP2013513607A5 publication Critical patent/JP2013513607A5/ja
Application granted granted Critical
Publication of JP5631411B2 publication Critical patent/JP5631411B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012543187A 2009-12-10 2010-12-07 ジアシルグリセロールアシルトランスフェラーゼの阻害剤 Expired - Fee Related JP5631411B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28531709P 2009-12-10 2009-12-10
US61/285,317 2009-12-10
PCT/US2010/059158 WO2011071840A1 (en) 2009-12-10 2010-12-07 Inhibitors of diacylglycerol acyltransferase

Publications (3)

Publication Number Publication Date
JP2013513607A JP2013513607A (ja) 2013-04-22
JP2013513607A5 true JP2013513607A5 (US20080242721A1-20081002-C00053.png) 2013-11-21
JP5631411B2 JP5631411B2 (ja) 2014-11-26

Family

ID=43569741

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012543187A Expired - Fee Related JP5631411B2 (ja) 2009-12-10 2010-12-07 ジアシルグリセロールアシルトランスフェラーゼの阻害剤

Country Status (14)

Country Link
US (1) US8299061B2 (US20080242721A1-20081002-C00053.png)
EP (1) EP2509981B1 (US20080242721A1-20081002-C00053.png)
JP (1) JP5631411B2 (US20080242721A1-20081002-C00053.png)
KR (1) KR101395428B1 (US20080242721A1-20081002-C00053.png)
CN (1) CN102666543B (US20080242721A1-20081002-C00053.png)
AR (1) AR079170A1 (US20080242721A1-20081002-C00053.png)
AU (1) AU2010328410B2 (US20080242721A1-20081002-C00053.png)
BR (1) BR112012013918A2 (US20080242721A1-20081002-C00053.png)
CA (1) CA2783684C (US20080242721A1-20081002-C00053.png)
EA (1) EA020128B1 (US20080242721A1-20081002-C00053.png)
ES (1) ES2509922T3 (US20080242721A1-20081002-C00053.png)
MX (1) MX2012006646A (US20080242721A1-20081002-C00053.png)
TW (1) TWI392680B (US20080242721A1-20081002-C00053.png)
WO (1) WO2011071840A1 (US20080242721A1-20081002-C00053.png)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3461556A1 (en) 2010-07-16 2019-04-03 AbbVie Ireland Unlimited Company Phosphine ligands for catalytic reactions
EP2593439B1 (en) 2010-07-16 2016-08-17 AbbVie Bahamas Ltd. Process for preparing antiviral compounds
US9255074B2 (en) 2010-07-16 2016-02-09 Abbvie Inc. Process for preparing antiviral compounds
US8975443B2 (en) 2010-07-16 2015-03-10 Abbvie Inc. Phosphine ligands for catalytic reactions
WO2015120610A1 (en) * 2014-02-14 2015-08-20 Eli Lilly And Company Gpr142 agonist compound
CN105153195B (zh) * 2015-09-01 2017-09-26 汤文建 一种三环吡唑[1,5‑d][1,4]苯并氧氮杂卓酮衍生物及其制备方法与用途
EP3978492A4 (en) * 2019-05-31 2023-06-28 Medshine Discovery Inc. Bicyclic compound as rip-1 kinase inhibitor and application thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0272866A1 (en) 1986-12-23 1988-06-29 Merck & Co. Inc. 1,4-Benzodiazepines with 5-membered heterocyclic rings
US4847248A (en) * 1986-12-23 1989-07-11 Merck & Co., Inc. 1,4-Benzodiazepines with 5- and 6-membered heterocyclic rings and their use as cholecystokinins and gastrin antagonists
US4735941A (en) * 1986-12-23 1988-04-05 Merck & Co., Inc. 1,4-benzodiazepines with 5- and 6-membered heterocyclic rings, useful as gastrointestinal and CNS agents
IL101850A (en) * 1991-06-13 1996-01-31 Janssen Pharmaceutica Nv History 11-) 4-Pipridinyl (-Imidazo] B-1, 2 [] 3 [Benzazepine, their preparation and pharmaceutical preparations containing them
EP0523846A3 (en) 1991-06-14 1993-03-17 Merck & Co. Inc. 1,4-benzodiazepines with 5-membered heterocyclic rings
PT730581E (pt) * 1993-11-22 2002-02-28 Merck & Co Inc 3-acilaminobenzazepinas
US5679672A (en) * 1993-11-22 1997-10-21 Merck & Co., Inc. Benzodiazepines
US5439906A (en) * 1993-11-22 1995-08-08 Merck & Co., Inc. Antiarrhythmic benzodiazepines
US5834464A (en) * 1994-11-18 1998-11-10 Merck & Co., Inc. Imidazolinobenzodiazepines
WO1998028268A2 (en) 1996-12-23 1998-07-02 Elan Pharmaceuticals, Inc. CYCLOALKYL, LACTAM, LACTONE AND RELATED COMPOUNDS AS β-AMYLOID PEPTIDE RELEASE INHIBITORS
GB0012671D0 (en) * 2000-05-24 2000-07-19 Merck Sharp & Dohme Therapeutic agents
CA2577060A1 (en) * 2004-08-13 2006-02-23 Amgen Inc. Substituted benzofused heterocycles
CN101171231A (zh) * 2005-05-10 2008-04-30 霍夫曼-拉罗奇有限公司 二酰基甘油酰基转移酶抑制剂
EP1912653B1 (en) 2005-07-29 2014-01-01 Merck Sharp & Dohme Corp. Heterocyclic benzodiazepine cgrp receptor antagonists
US7569590B2 (en) 2006-09-19 2009-08-04 Bristol-Myers Squibb Company Use of thianecarboxamides as dgat inhibitors
WO2009126624A1 (en) 2008-04-11 2009-10-15 Bristol-Myers Squibb Company Triazolo compounds useful as dgat1 inhibitors
US8394823B2 (en) 2008-04-11 2013-03-12 Bristol-Myers Squibb Company Triazolopyridine compounds useful as DGAT1 inhibitors
JP2010116364A (ja) 2008-11-14 2010-05-27 Banyu Pharmaceut Co Ltd アゼピノン誘導体
WO2010084979A1 (en) 2009-01-23 2010-07-29 Banyu Pharmaceutical Co.,Ltd. Benzodiazepin-2-on derivatives
AU2010216632A1 (en) 2009-02-17 2011-08-04 Msd K.K. 1,4-benzodiazepin-2-on derivatives

Similar Documents

Publication Publication Date Title
JP2013507423A5 (US20080242721A1-20081002-C00053.png)
JP2013513607A5 (US20080242721A1-20081002-C00053.png)
JP2012506896A5 (US20080242721A1-20081002-C00053.png)
JP2013032389A5 (US20080242721A1-20081002-C00053.png)
JP2010536766A5 (US20080242721A1-20081002-C00053.png)
JP2014500861A5 (US20080242721A1-20081002-C00053.png)
JP2013508279A5 (US20080242721A1-20081002-C00053.png)
JP2011518833A5 (US20080242721A1-20081002-C00053.png)
JP2011105738A5 (US20080242721A1-20081002-C00053.png)
JP2012502037A5 (US20080242721A1-20081002-C00053.png)
JP2013518107A5 (US20080242721A1-20081002-C00053.png)
JP2012092103A5 (US20080242721A1-20081002-C00053.png)
JP2013509429A5 (US20080242721A1-20081002-C00053.png)
JP2010077141A5 (US20080242721A1-20081002-C00053.png)
JP2016006118A5 (US20080242721A1-20081002-C00053.png)
JP2015024998A5 (US20080242721A1-20081002-C00053.png)
JP2015505296A5 (US20080242721A1-20081002-C00053.png)
JP2009535462A5 (US20080242721A1-20081002-C00053.png)
JP2013542247A5 (US20080242721A1-20081002-C00053.png)
JP2011527299A5 (US20080242721A1-20081002-C00053.png)
JP2015516427A5 (US20080242721A1-20081002-C00053.png)
JP2012532883A5 (US20080242721A1-20081002-C00053.png)
JP2014507477A5 (US20080242721A1-20081002-C00053.png)
JP2007302689A5 (US20080242721A1-20081002-C00053.png)
JP2012512863A5 (US20080242721A1-20081002-C00053.png)